Molbio Diagnostics IPO Subscription
The Molbio Diagnostics IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
As per the latest subscription update, the Molbio Diagnostics IPO has received bids for 57,32,14,536 shares against 81,58,529 shares offered, resulting in an overall subscription of 70.26x. the NII category is subscribed 49.8x, Retail Investors 12.96x, Employees 13.28x, and QIBs 186.39x. Within the NII category, BNII is subscribed 50.82x, while SNII is subscribed 47.76x.
Subscription Highlights
- Overall Subscription: 70.26x
- QIB Subscription: 186.39x
- NII Subscription: 49.8x
- BNII Subscription: 50.82x
- SNII Subscription: 47.76x
- Retail Subscription: 12.96x
- Employee Subscription: 13.28x
- Retail
- 12.96x
- NII
- 49.8x
- QIB
- 186.39x
- Total
- 70.26x
Current GMP
₹126 (+15.61%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Molbio Diagnostics IPO Subscription Details ( Wed, 12 Aug 26 01:56 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 2,325,145 | 433,382,148 | 186.39x |
| Non-Institutional | 1,743,860 | 86,840,604 | 49.8x |
| BNII (>₹10L) | 1,162,574 | 59,076,594 | 50.82x |
| SNII (₹2L–₹10L) | 581,286 | 27,764,010 | 47.76x |
| Retail Investors | 4,069,005 | 52,719,318 | 12.96x |
| Employees | 20,519 | 272,466 | 13.28x |
| Total | 8,158,529 | 573,214,536 | 70.26x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved | Applied | Times (x) |
|---|---|---|---|
| Non-Institutional | 6,920 | 0 | - |
| BNII (>₹10L) | 4,613 | 0 | - |
| SNII (₹2L–₹10L) | 2,307 | 0 | - |
| Retail Investors | 226,056 | 0 | - |
| Employees | - | 0 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Molbio Diagnostics IPO Live Subscription Status?
You can check the Molbio Diagnostics IPO live subscription status on the IPO Master App or the official websites of the BSE,NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Molbio Diagnostics IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Molbio Diagnostics IPO was subscribed 12.96 times as of Wed, Aug 12, 2026 07:26 PM. The public issue closed on Wed, Aug 12, 2026 for bidding.
How to subscribe Molbio Diagnostics IPO?
Investors can apply for the Molbio Diagnostics IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Molbio Diagnostics IPO subscribed?
The Molbio Diagnostics IPO was subscribed 70.26x times at the close of bidding period on Wed, Aug 12, 2026.
How to check Molbio Diagnostics IPO allotment?
The Molbio Diagnostics IPO allotment was finalized on Thu, Aug 13, 2026. You can check the Molbio Diagnostics IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Molbio Diagnostics IPO Be Listed?
The Molbio Diagnostics IPO is tentatively scheduled to be listed on Mon, Aug 17, 2026, on the BSE,NSE. The final listing date is subject to the successful completion of the IPO allotment process and regulatory approvals.
What is the Molbio Diagnostics IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Molbio Diagnostics IPO was subscribed 186.39 times as of Wed, Aug 12, 2026 07:26 PM.